Xuanhui Wei
Overview
Explore the profile of Xuanhui Wei including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
96
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wu H, Wang H, Zhang W, Wei X, Zhao J, Yan P, et al.
Int J Clin Exp Pathol
. 2015 Aug;
8(6):6870-80.
PMID: 26261574
The aim of this study was to elucidate the signaling pathway involved in the anti-aging effect of erythropoietin (EPO) and to clarify whether recombinant human EPO (rhEPO) affects apoptosis in...
2.
Yang H, Xiong F, Wei X, Yang Y, McNutt M, Zhou R
Cancer Lett
. 2010 Mar;
294(2):236-44.
PMID: 20202745
LAPTM4B-35, encoded by Lysosomal protein transmembrane 4 beta (LAPTM4B) is over-expressed in more than 71% of hepatocellular carcinomas (HCCs) and associated with prognosis of the patients. But the exact role...
3.
Liu X, Xiong F, Wei X, Yang H, Zhou R
Cancer Sci
. 2009 Oct;
100(12):2335-40.
PMID: 19843073
Lysosomal protein transmembrane 4 beta (LAPTM4B) was originally identified as a hepatocellular carcinoma (HCC)-associated gene. This gene and its protein product LAPTM4B-35, are both overexpressed in a variety of human...
4.
Wei X, Ru S, Jiang M, Li Y
Ying Yong Sheng Tai Xue Bao
. 2004 Mar;
14(12):2289-94.
PMID: 15031937
The exposure of Sciaenops ocellatus to monocrotophos at its concentration of 0.25, 0.5, 1.0 or 2.0 mg L-1 for 4 days demonstrated that under the stress of low concentration (0.25...